COVID-19: Pain Management in Patients with SARS-CoV-2 Infection—Molecular Mechanisms, Challenges, and Perspectives
Open Access
- 19 July 2020
- journal article
- opinion
- Published by MDPI AG in Brain Sciences
- Vol. 10 (7), 465
- https://doi.org/10.3390/brainsci10070465
Abstract
Since the end of 2019, the whole world has been struggling with the pandemic of the new Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Available evidence suggests that pain is a common symptom during Coronavirus Disease 2019 (COVID-19). According to the World Health Organization, many patients suffer from muscle pain (myalgia) and/or joint pain (arthralgia), sore throat and headache. The exact mechanisms of headache and myalgia during viral infection are still unknown. Moreover, many patients with respiratory failure get admitted to the intensive care unit (ICU) for ventilatory support. Pain in ICU patients can be associated with viral disease itself (myalgia, arthralgia, peripheral neuropathies), may be caused by continuous pain and discomfort associated with ICU treatment, intermittent procedural pain and chronic pain present before admission to the ICU. Undertreatment of pain, especially when sedation and neuromuscular blocking agents are used, prone positioning during mechanical ventilation or extracorporeal membrane oxygenation (ECMO) may trigger delirium and cause peripheral neuropathies. This narrative review summarizes current knowledge regarding challenges associated with pain assessment and management in COVID-19 patients. A structured prospective evaluation should be undertaken to analyze the probability, severity, sources and adequate treatment of pain in patients with COVID-19 infection.This publication has 112 references indexed in Scilit:
- Using Laboratory Models to Test TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal CordJournal of Neuroscience, 2009
- The management of coronavirus infections with particular reference to SARSJournal of Antimicrobial Chemotherapy, 2008
- Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory SyndromeJournal of Virology, 2008
- Use of Nonsteroidal Antiinflammatory DrugsCirculation, 2007
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Effects of Fentanyl on Natural Killer Cell Activity and on Resistance to Tumor Metastasis in RatsNeuroimmunomodulation, 2004
- Effects of Anesthesia Based on Large Versus Small Doses of Fentanyl on Natural Killer Cell Cytotoxicity in the Perioperative PeriodAnesthesia & Analgesia, 1996
- The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1Nature, 1994
- Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood GasesThe New England Journal of Medicine, 1981